QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $21,000 | -54.3% | 80,094 | 0.0% | 0.02% | -51.4% |
Q2 2022 | $46,000 | -13.2% | 80,094 | 0.0% | 0.04% | +5.7% |
Q1 2022 | $53,000 | -38.4% | 80,094 | 0.0% | 0.04% | -36.4% |
Q4 2021 | $86,000 | -17.3% | 80,094 | 0.0% | 0.06% | -28.6% |
Q3 2021 | $104,000 | -34.6% | 80,094 | 0.0% | 0.08% | -34.2% |
Q2 2021 | $159,000 | -26.4% | 80,094 | 0.0% | 0.12% | -32.0% |
Q1 2021 | $216,000 | – | 80,094 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HighMark Wealth Management LLC | 80,094 | $104,000 | 0.08% |
PERKINS CAPITAL MANAGEMENT INC | 51,178 | $67,000 | 0.04% |
HATTON CONSULTING, INC. | 27,195 | $35,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 78,687 | $102,000 | 0.01% |
CRA Financial Services, LLC | 19,957 | $26,000 | 0.01% |
Virtu Financial LLC | 25,507 | $33,000 | 0.00% |
WEDBUSH SECURITIES INC | 32,228 | $42,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 15,347 | $20,000 | 0.00% |
UBS Group AG | 13,118 | $17,000 | 0.00% |
US BANCORP \DE\ | 9,047 | $12,000 | 0.00% |